Brain tumors in S100beta-v-erbB transgenic rats. (Q48347824)

10 February 2018

title

Brain tumors in S100beta-v-erbB transgenic rats. (English)

1 reference

10 February 2018

1 reference

7

1 reference

10 February 2018

author name string

Hiroko Ohgaki

1

1 reference

10 February 2018

Daisuke Kita

2

1 reference

10 February 2018

Alexandre Favereaux

3

1 reference

10 February 2018

Herve Huang

4

1 reference

10 February 2018

Taku Homma

5

1 reference

10 February 2018

Pierre Dessen

6

1 reference

10 February 2018

Paul Kleihues

8

1 reference

10 February 2018

Frank L Heppner

9

1 reference

10 February 2018

publication date

1 December 2006

1 reference

10 February 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

10 February 2018

volume

65

1 reference

10 February 2018

page(s)

1111-1117

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Molecular pathogenesis of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Frequency of spontaneous tumors in Wistar rats in 30-months studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

A novel animal model of thymic tumour: development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

21 January 2018

Lentiviral transgenesis

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Production of transgenic rats by lentiviral transduction of male germ-line stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Transgenic modifications of the rat genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Evaluation of ENU-induced gliomas in rats: nomenclature, immunochemistry, and malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Spatial and temporal expression of S100B in cells of oligodendrocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

EGF mutant receptor vIII as a molecular target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Genetics and new approaches to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

EGFR gene amplification--rearrangement in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000248544.28423.48

10.1097/01.JNEN.0000248544.28423.48

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

17146284

1 reference

10 February 2018